Clinical Trial Update: Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly [Phase 1]

View source ↗

Summary

Phase I trial evaluating ONX-0801 given weekly or every other week in patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ONX-0801

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED